Cargando…
Possibly propylthiouracil-induced antineutrophilic cytoplasmic antibody-associated vasculitis manifested as blood coagulation disorders: A case report
BACKGROUND: Propylthiouracil is the most common drug used to treat hyperthyroidism. However, this drug could cause a severe disease, antineutrophilic cytoplasmic antibody-associated vasculitis (AAV), which was usually misdiagnosed. METHODS: We reported a 60-year-old woman of propylthiouracil-induced...
Autores principales: | Yi, Xiao-Yan, Wang, Yao, Li, Qi-Fu, Li, Rong, Yang, Shu-Min, Zhou, Guo-Qing, Wang, Zhi-Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5072949/ https://www.ncbi.nlm.nih.gov/pubmed/27741122 http://dx.doi.org/10.1097/MD.0000000000005068 |
Ejemplares similares
-
Propylthiouracil-induced Otitis Media with Antineutrophil Cytoplasmic Antibody-associated Vasculitis
por: Tanaka, Rika, et al.
Publicado: (2018) -
Propylthiouracil-Induced Antineutrophil Cytoplasmic Antibodies-Associated Vasculitis with Renal and Lung Involvement
por: Wong, Albert Hing, et al.
Publicado: (2022) -
Epitope analysis of anti-myeloperoxidase antibodies in propylthiouracil-induced antineutrophil cytoplasmic antibody-associated vasculitis
por: Wang, Chen, et al.
Publicado: (2013) -
Propylthiouracil-Induced Antineutrophil Cytoplasmic Antibody-Associated Vasculitis after COVID-19 Vaccination
por: Okuda, Saki, et al.
Publicado: (2021) -
Propylthiouracil-induced antineutrophil cytoplasmic antibody-associated vasculitis and agranulocytosis in a patient with Graves’ disease
por: Tomkins, Maria, et al.
Publicado: (2019)